We are live on ! Find out more
ARWR icon

Arrowhead Research

278 hedge funds and large institutions have $2.36B invested in Arrowhead Research in 2022 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 98 increasing their positions, 97 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

28% more call options, than puts

Call options by funds: $19.4M | Put options by funds: $15.2M

8% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 26

1% more repeat investments, than reductions

Existing positions increased: 98 | Existing positions reduced: 97

0% less funds holding

Funds holding: 279278 (-1)

0.62% less ownership

Funds ownership: 68.31%67.69% (-0.62%)

7% less capital invested

Capital invested by funds: $2.54B → $2.36B (-$171M)

20% less funds holding in top 10

Funds holding in top 10: 54 (-1)

Holders
278
Holders Change
-1
Holders Change %
-0.36%
% of All Funds
4.79%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.07%
New
28
Increased
98
Reduced
97
Closed
26
Calls
$19.4M
Puts
$15.2M
Net Calls
+$4.19M
Net Calls Change
+$3.82M
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$400M -$7.93M -196,385 -2%
Vanguard Group
2
Vanguard Group
Pennsylvania
$335M +$3.09M +76,653 +0.8%
State Street
3
State Street
Massachusetts
$174M -$13.2M -328,314 -6%
JP Morgan Chase
4
JP Morgan Chase
New York
$95.6M -$3.97M -98,294 -3%
AllianceBernstein
5
AllianceBernstein
Tennessee
$81.5M -$13.4M -331,074 -12%
Fidelity Investments
6
Fidelity Investments
Massachusetts
$81M -$11.8M -293,242 -11%
Invesco
7
Invesco
Georgia
$73.2M +$587K +14,555 +0.7%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$62.4M +$1.45M +36,020 +2%
CS
9
Credit Suisse
Switzerland
$42.4M -$8.27K -205 -0%
Northern Trust
10
Northern Trust
Illinois
$42.3M -$690K -17,087 -1%
APM
11
Avidity Partners Management
Texas
$41.5M -$7.41M -183,625 -13%
ACM
12
Aquilo Capital Management
California
$40.3M +$807K +20,000 +2%
Norges Bank
13
Norges Bank
Norway
$40.1M +$1.68M +41,610 +4%
Janus Henderson Group
14
Janus Henderson Group
United Kingdom
$37.6M +$22.9M +567,036 +99%
First Manhattan
15
First Manhattan
New York
$36.5M -$43.4K -1,075 -0.1%
Charles Schwab
16
Charles Schwab
California
$36.5M +$1.01M +25,055 +2%
Bank of New York Mellon
17
Bank of New York Mellon
New York
$35.5M +$1.5M +37,243 +4%
Goldman Sachs
18
Goldman Sachs
New York
$33.8M +$1.89M +46,737 +5%
Fiera Capital (Canada)
19
Fiera Capital (Canada)
Quebec, Canada
$33.2M -$984K -24,371 -2%
WFC
20
Western Financial Corp
California
$27.1M
Renaissance Technologies
21
Renaissance Technologies
New York
$25M +$12.7M +314,400 +71%
Point72 Asset Management
22
Point72 Asset Management
Connecticut
$22M +$10.9M +270,732 +68%
Citadel Advisors
23
Citadel Advisors
Florida
$18.3M +$7.26M +179,851 +48%
Ameriprise
24
Ameriprise
Minnesota
$17.5M -$301K -7,460 -1%
Bank of America
25
Bank of America
North Carolina
$16.1M -$4.85M -120,257 -20%

ARWR Hedge Fund Activity: Q3 2022 in Review

278 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Arrowhead Research (ARWR) for Q3 2022, worth a combined $2.36B — down 6.8% from $2.54B a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new ARWR positions and 26 closed out — a net gain of 2 holders — while 98 added to existing stakes and 97 trimmed.

The largest buyer was Janus Henderson Group, adding an estimated $22.9M. The largest seller was Johnson & Johnson, cutting an estimated $40.9M.

  • 278 institutional investors held Arrowhead Research (ARWR) as of Q3 2022, down from 279 in Q2 2022.
  • Funds reported $2.36B of Arrowhead Research stock for Q3 2022, down 6.8% quarter-over-quarter.
  • 28 funds opened new Arrowhead Research positions in Q3 2022 and 26 closed out, a net change of +2 holders.
  • The largest Arrowhead Research buyer in Q3 2022 was Janus Henderson Group, an estimated $22.9M added.
  • The largest Arrowhead Research seller in Q3 2022 was Johnson & Johnson, an estimated $40.9M sold.

Based on aggregated 13F filings for Q3 2022.